retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial vs Survodutide: vs Dual Comparison for and MASH - Which Is Better? Retatrutide: How Triple GLP-1/GIP/Glucagon Receptor

Additionally, Mounjaro , one of the newer diabetes drugs, which was approved in May 2022 and has a unique dual mechanism of action (it activates the GLP-1 hormone as well as another hormone called the glucose-dependent insulinotropic polypeptide or GIP, both helping to improve blood sugar) may be even more effective than semaglutide in reducing weight

Working with a clinician who monitors response, side effects, and safety markers, and who adjusts the dose or medication as needed, is part of safe GLP-1 prescribing

Insulin resistance can cause hyperinsulinemia (high insulin) and affect hormones that regulate appetite, both of which could drive excess calorie intake and lead to weight gain or obesity

The medication also helps improve how your body uses insulin, which can be beneficial for people who have both weight concerns and blood sugar issues

serotonin syndrome can also be caused by other medications including triptans, antidepressants, lithium, tramadol, buspirone, and others